These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 16759311
21. Modulation of aldosterone levels by aldosterone synthase promoter polymorphism and association with eGFR decline in patients with chronic kidney disease. Qian J, Zhong J, Yan M, Shi H, Hao C, Gu Y, Lai L. Discov Med; 2018 Dec; 26(145):251-260. PubMed ID: 30695674 [Abstract] [Full Text] [Related]
22. Lack of association between CYP11B2 -344T/C polymorphism and transient ischemic attack in a Chinese population. Fan J, Shen Y, Chen B, Xu C, Ye H, Wang J, Zhou W, Sheng Y, Xu F, Yang P. J Int Med Res; 2020 Aug; 48(8):300060520947916. PubMed ID: 32790508 [Abstract] [Full Text] [Related]
26. Association of aldosterone synthase CYP11B2 (-344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population. Abdel Ghafar MT. Clin Exp Hypertens; 2019 May; 41(8):779-786. PubMed ID: 30561227 [Abstract] [Full Text] [Related]
27. Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis. Sookoian S, Gianotti TF, González CD, Pirola CJ. J Hypertens; 2007 Jan; 25(1):5-13. PubMed ID: 17143166 [Abstract] [Full Text] [Related]
28. [Association of aldosterone synthase gene -344T/C polymorphism with plasma aldosterone and angiotensin II concentration in hypertensive patients]. Hu BC, Chu SL, Wang JG, Wang ZH, Wang GL, Gao PJ, Zhu DL. Zhonghua Yi Xue Za Zhi; 2006 Apr 25; 86(16):1144-7. PubMed ID: 16796847 [Abstract] [Full Text] [Related]
30. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years. Huang XH, Rantalaiho V, Wirta O, Pasternack A, Hiltunen TP, Koivula T, Malminiemi K, Nikkari T, Lehtimäki T. Nephron; 1998 Sep 25; 80(1):17-24. PubMed ID: 9730698 [Abstract] [Full Text] [Related]
31. CYP11B2 gene polymorphism and essential hypertension among Tibetan, Dongxiang and Han populations from northwest of China. Li X, Xie P, He J, Cai H, Yang R, Zhang Q, Li B, Qi W, Ma H. Clin Exp Hypertens; 2016 Sep 25; 38(4):375-80. PubMed ID: 27149293 [Abstract] [Full Text] [Related]
33. [Association of aldosterone synthase gene -344 T/C polymorphism with early renal damage in Han nationality with essential hypertension]. Sun XJ, Liu SR, Zhang CH, Yuan GH, Chen HY, Hou XF. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr 25; 24(2):153-6. PubMed ID: 17407071 [Abstract] [Full Text] [Related]
34. [The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors]. Tarnow L, Parving HH, Jacobsen P, Rossing P, Lecerf L, Poirier O, Cambien F. Ugeskr Laeger; 1998 Aug 17; 160(34):4886-9. PubMed ID: 9741257 [Abstract] [Full Text] [Related]
35. Relationship between -344T/C polymorphism in the aldosterone synthase gene and atrial fibrillation in patients with essential hypertension. Sun X, Yang J, Hou X, Li J, Shi Y, Jing Y. J Renin Angiotensin Aldosterone Syst; 2011 Dec 17; 12(4):557-63. PubMed ID: 21846681 [Abstract] [Full Text] [Related]
38. Association of renin-angiotensin system genes polymorphism with progression of diabetic nephropathy in patients with type 1 diabetes mellitus. Ilić V, Ilić M, Soldatović I, Popović S, Magić Z. Vojnosanit Pregl; 2014 Jul 17; 71(7):627-33. PubMed ID: 25109108 [Abstract] [Full Text] [Related]